Darius N. Lakdawalla
University of Southern California
H-index: 54
North America-United States
Top articles of Darius N. Lakdawalla
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Risk preferences over health: empirical estimates and implications for medical decision-making | Journal of Health Economics | Karen Mulligan Drishti Baid Jason N Doctor Charles E Phelps Darius N Lakdawalla | 2024/3/1 |
A principled approach to non-discrimination in cost-effectiveness | The European Journal of Health Economics | Darius N Lakdawalla Jason N Doctor | 2024/2/27 |
Valuing Health: The Generalized and Risk-adjusted Cost-effectiveness (GRACE) Model | Charles E Phelps Darius N Lakdawalla | 2024/2/9 | |
Prescription drug advertising and drug utilization: The role of Medicare Part D | Journal of public economics | Abby Alpert Darius Lakdawalla Neeraj Sood | 2023/5/1 |
Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials | Jessica B Langbaum Julie Zissimopoulos Rhoda Au Niranjan Bose Chris J Edgar | 2023/2 | |
The Value of Health and Longevity with Stochastic Health Risk and Partial Annuitization | Univa Song Daniel Bauer Darius Lakdawalla Julian Reif | 2023/12 | |
Mitigating the Inflation Reduction Act’s adverse impacts on the prescription drug market | Schaeffer Center White Paper Series | Dana Goldman Joe Grogan Darious Lakdawalla Barry Liden Jason Shafrin | 2023/4 |
Alternatives to the QALY for comparative effectiveness research | Health Affairs Forefront | Sean D Sullivan Darius N Lakdawalla Beth Devine Jens Grueger Louis P Garrison Jr | 2023/11/21 |
A strategy for value-based drug pricing under the inflation reduction act | Health Affairs Forefront | Jason Shafrin Darius N Lakdawalla Jalpa A Doshi Louis P Garrison Jr Anup Malani | 2023 |
Benefits of Medicare Coverage for Weight Loss Drugs | Alison Sexton Ward Bryan Tysinger PhuongGiang Nguyen Dana Goldman Darius Lakdawalla | 2023/4 | |
Methods to adjust willingness-to-pay measures for severity of illness | Value in Health | Charles E Phelps Darius N Lakdawalla | 2023/7/1 |
The generalized risk-adjusted cost-effectiveness (GRACE) model for measuring the value of gains in health: an exact formulation | Journal of Benefit-Cost Analysis | Darius N Lakdawalla Charles E Phelps | 2023/3 |
Health risk and the value of life | Working Paper | Daniel Bauer Darius Lakdawalla Julian Reif | 2022/6/27 |
Assessment of Medical and Public Assistance Expenditures and Employment Among US Adults With Cancer Diagnoses | JAMA Network Open | David C Grabowski Anuraag R Kansal Dana P Goldman Darius N Lakdawalla | 2023/5/1 |
Cancer-Related Technologies Have Changed a Lot. So Should Cancer Screening. | Dana Goldman Darius Lakdawalla Karen Van Nuys | 2023/2 | |
Increased lifetime risk of intestinal complications and extraintestinal manifestations in Crohn’s disease and ulcerative colitis | Gastroenterology & Hepatology | Gary R Lichtenstein Ahva Shahabi Seth A Seabury Darius N Lakdawalla Oliver Díaz Espinosa | 2022/1 |
Value of reducing wait times for chimeric antigen receptor T-cell treatment: Evidence from randomized controlled trial data on tisagenlecleucel for diffuse large B-cell lymphoma | Value in Health | Alice J Chen Jie Zhang Abhijit Agarwal Darius N Lakdawalla | 2022/8/1 |
EE354 Heterogeneity in the Economic Value of Early Alzheimer's Disease-Modifying Therapies: An Analysis of Patient Subgroups | J Yu B Tysinger J Hlávka D Lakdawalla | 2022/7/1 | |
A guide to extending and implementing generalized risk-adjusted cost-effectiveness (GRACE) | The European Journal of Health Economics | Darius N Lakdawalla Charles E Phelps | 2022/4 |
Access to disease-modifying Alzheimer’s therapies: addressing possible challenges using innovative payment models | Value in Health | Jakub P Hlávka Bryan Tysinger C Yu Jeffrey Darius N Lakdawalla | 2022/11/1 |
Co-Authors
